How Ph.D. was paid
$2.2M in total for 2025, as reported in the Summary Compensation Table. Equity awards are valued at grant, not at what they turned out to be worth.
Named executive officers
| Executive | Salary | Bonus | Options | Incentive | Other | Total |
|---|---|---|---|---|---|---|
| Amit Etkin, M.D., Ph.D.President, Chief Executive Officer, and Chair of the Board | $650,671 | $220,000 | $934,186 | $358,072 | $25,558 | $2,188,487 |
| Nicholas SmithChief Financial Officer and Chief Business Officer | $493,720 | $220,000 | $594,723 | $222,300 | $10,842 | $1,541,585 |
| Michael HanleyChief Operating Officer | $488,800 | — | $517,598 | $195,520 | $11,010 | $1,212,928 |
What changed and why
- $4.1MCEO total compensation decreased from $4,065,848 in 2024 to $2,188,487 in 2025 due to lower option award values.
- $220KDr. Etkin received a discretionary bonus of $220,000 for asset acquisitions and private placement financing.
- $2.35Option awards in 2025 included incremental fair values resulting from a one-time stock option repricing to $2.35 per share.
- 100%Corporate goal attainment for the 2025 annual cash incentive was determined to be 100% by the Compensation Committee.
- 55%Dr. Etkin's base salary for 2025 was set at $650,671 with a cash incentive target of 55%.
About this page
Figures are automated and can be wrong; check the filing for the exact numbers. Totals follow SEC rules, which value stock and option awards at grant. Read the DEF 14A proxy statement for footnotes and the compensation committee's full reasoning.